Physician profile
Brian Eugene Lee
NPI 1831533231
$1,242.93
in general payments reported to CMS, 2019-2025
9 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $259 · 2021: $507 · 2022: $131 · 2023: $20.04 · 2024: $105 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $445.27 | 2021-2024 | Penumbra System |
| Inari Medical, INC. | $189.56 | 2021 | |
| Stryker Corporation | $177.23 | 2020-2025 | Alphavent |
| Delcath Systems | $175.03 | 2025 | Hepzato Kit |
| Ethicon US, LLC | $104.30 | 2021 | |
| Bard Peripheral Vascular, INC. | $65.88 | 2020 | |
| Terumo Medical Corporation | $61.37 | 2020 | |
| Janssen Pharmaceuticals, INC | $20.04 | 2023 | Xarelto |
| Cardiovascular Systems INC. | $4.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.